Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics
Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics
预测未来：13位分析师对nurix therapeutics的预测
Throughout the last three months, 13 analysts have evaluated Nurix Therapeutics (NASDAQ:NRIX), offering a diverse set of opinions from bullish to bearish.
过去三个月，13位分析师对 Nurix Therapeutics（纳斯达克股票代码：NRIX）进行了评估，提供了从看好到看淡的不同观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估，下表展示了过去30天内不断变化的情绪，并将其与之前的几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $29.54, a high estimate of $36.00, and a low estimate of $20.00. This current average reflects an increase of 6.64% from the previous average price target of $27.70.
分析师们12个月的目标股价的见解被揭示，显示出一个平均目标为29.54美元、一个最高估值为36.00美元和一个最低估值为20.00美元。当前的平均目标股价反映了6.64%的上涨，相对于之前的平均目标股价27.70美元。
Deciphering Analyst Ratings: An In-Depth Analysis
分析师评级解读：深入分析
The standing of Nurix Therapeutics among financial experts becomes clear with a thorough...
通过对最近分析师行为的彻底...
登录免费看全文
登录/注册